Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway.
about
Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia.Cell Cycle Regulation of Stem Cells by MicroRNAs.Caffeic Acid Phenethyl Ester Induces N-myc Downstream Regulated Gene 1 to Inhibit Cell Proliferation and Invasion of Human Nasopharyngeal Cancer Cells.
P2860
Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Concurrent treatment with simv ...... let-7 miRNA signaling pathway.
@en
type
label
Concurrent treatment with simv ...... let-7 miRNA signaling pathway.
@en
prefLabel
Concurrent treatment with simv ...... let-7 miRNA signaling pathway.
@en
P2093
P2860
P1433
P1476
Concurrent treatment with simv ...... /let-7 miRNA signaling pathway
@en
P2093
Chang Wook Jeong
Hye Sun Lee
Hyeon Hoe Kim
Ja Hyeon Ku
Kyoung-Hwa Lee
Minyong Kang
P2860
P304
P356
10.1371/JOURNAL.PONE.0184644
P407
P50
P577
2017-09-14T00:00:00Z